NDC Package 55513-485-96 Otezla

Apremilast Kit - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
55513-485-96
Package Description:
5 BLISTER PACK in 1 CARTON / 1 KIT in 1 BLISTER PACK (55513-485-95)
Product Code:
Proprietary Name:
Otezla
Non-Proprietary Name:
Apremilast
Usage Information:
This medication is used to treat a certain type of arthritis (psoriatic arthritis). Apremilast is also used to treat a certain type of skin condition (moderate to severe plaque psoriasis). Apremilast belongs to a class of drugs known as phosphodiesterase 4 (PDE4) inhibitors. For the treatment of psoriatic arthritis, it decreases pain and swelling, and may help improve flexibility in the affected joints. For the treatment of plaque psoriasis, it may help to reduce the redness, thickening, and scaling of the skin that occurs with this condition. Apremilast is also used to treat mouth sores in people who have Behcet's disease. It helps to reduce the pain and improve the healing of these mouth sores.
11-Digit NDC Billing Format:
55513048596
NDC to RxNorm Crosswalk:
  • RxCUI: 1492732 - apremilast 10 MG Oral Tablet
  • RxCUI: 1492738 - Otezla 10 MG Oral Tablet
  • RxCUI: 1492738 - apremilast 10 MG Oral Tablet [Otezla]
  • RxCUI: 1492740 - apremilast 20 MG Oral Tablet
  • RxCUI: 1492742 - Otezla 20 MG Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Amgen Inc
    Dosage Form:
    Kit - A packaged collection of related material.
    Sample Package:
    Yes
    FDA Application Number:
    NDA205437
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    02-26-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 55513-485-96?

    The NDC Packaged Code 55513-485-96 is assigned to a package of 5 blister pack in 1 carton / 1 kit in 1 blister pack (55513-485-95) of Otezla, a human prescription drug labeled by Amgen Inc. The product's dosage form is kit and is administered via form.

    Is NDC 55513-485 included in the NDC Directory?

    Yes, Otezla with product code 55513-485 is active and included in the NDC Directory. The product was first marketed by Amgen Inc on February 26, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 55513-485-96?

    The 11-digit format is 55513048596. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-255513-485-965-4-255513-0485-96